Therefore, it is of great clinical significance to reveal the pathogenesis of hypoadiponectinemia and improve the serum adiponectin level to prevent and treat associated systemic diseases, especially insulin resistance and T2D [14, 15]. The gene discussed is ADIPOQ; the disease is Insulin resistance.